- Home
- PENN vs BCRX Comparison
PENN vs BCRX Comparison
Compare PENN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PENN | BCRX |
|---|---|---|
| Founded | 1972 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PENN | BCRX |
|---|---|---|
| Price | $17.94 | $9.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $20.83 | $20.82 |
| AVG Volume (30 Days) | 2.5M | ★ 3.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $6,362,900,000.00 | $25,186,000.00 |
| Revenue This Year | $6.85 | N/A |
| Revenue Next Year | $3.83 | $12.55 |
| P/E Ratio | $77.17 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.65 | $6.00 |
| 52 Week High | $22.36 | $11.22 |
Technical Indicators
Market Signals| Indicator | PENN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.47 | 51.84 |
| Support Level | $13.37 | $8.79 |
| Resistance Level | $18.25 | $10.01 |
| Average True Range (ATR) | 0.60 | 0.45 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 0.63 | 37.93 |
Price Performance
Historical ComparisonAbout PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 42 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 81% of total sales in 2025; 19% was from the interactive segment, which includes sports, i-gaming, and media revenue. The retail portfolio generates low-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/i-gaming technology and clientele, helping it form a leading digital position.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.